Omega Healthcare Investors (NYSE:OHI) Hits New 52-Week High – Time to Buy?

Omega Healthcare Investors, Inc. (NYSE:OHIGet Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $43.48 and last traded at $43.45, with a volume of 523796 shares traded. The stock had previously closed at $42.98.

Analyst Ratings Changes

OHI has been the subject of several research reports. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Truist Financial boosted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada boosted their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a research note on Thursday, August 7th. Scotiabank upped their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $43.86.

Read Our Latest Report on OHI

Omega Healthcare Investors Trading Down 0.1%

The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $12.67 billion, a P/E ratio of 26.48, a P/E/G ratio of 1.85 and a beta of 0.69. The firm has a 50-day moving average of $41.49 and a two-hundred day moving average of $39.18.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last issued its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, beating the consensus estimate of $0.77 by $0.02. The business had revenue of $260.74 million during the quarter, compared to the consensus estimate of $262.48 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm’s revenue was up 14.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 3rd will be given a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, November 3rd. This represents a $2.68 annualized dividend and a dividend yield of 6.2%. Omega Healthcare Investors’s payout ratio is presently 149.72%.

Insider Transactions at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.50% of the stock is owned by company insiders.

Institutional Trading of Omega Healthcare Investors

A number of hedge funds have recently made changes to their positions in OHI. State of Michigan Retirement System increased its position in shares of Omega Healthcare Investors by 1.0% during the 3rd quarter. State of Michigan Retirement System now owns 70,263 shares of the real estate investment trust’s stock valued at $2,967,000 after purchasing an additional 700 shares during the last quarter. Capital Investment Advisory Services LLC grew its position in Omega Healthcare Investors by 2.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 27,984 shares of the real estate investment trust’s stock worth $1,182,000 after acquiring an additional 552 shares during the last quarter. Prasad Wealth Partners LLC bought a new position in Omega Healthcare Investors during the 3rd quarter worth approximately $224,000. MONECO Advisors LLC grew its position in Omega Healthcare Investors by 6.4% during the 3rd quarter. MONECO Advisors LLC now owns 6,659 shares of the real estate investment trust’s stock worth $281,000 after acquiring an additional 403 shares during the last quarter. Finally, Waterloo Capital L.P. grew its position in Omega Healthcare Investors by 4.7% during the 3rd quarter. Waterloo Capital L.P. now owns 120,024 shares of the real estate investment trust’s stock worth $5,067,000 after acquiring an additional 5,357 shares during the last quarter. 65.25% of the stock is owned by institutional investors.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

See Also

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.